Coordinated elevation of membrane type 1-matrix metalloproteinase and matrix metalloproteinase-2 expression in rat uterus during postpartum involution
© Kengo et al; licensee BioMed Central Ltd. 2006
Received: 23 February 2006
Accepted: 02 June 2006
Published: 02 June 2006
The changes occurring in the rodent uterus after parturition can be used as a model of extensive tissue remodeling. As the uterus returns to its prepregnancy state, the involuting uterus undergoes a rapid reduction in size primarily due to the degradation of the extracellular matrix, particularly collagen. Membrane type-I matrix metalloproteinase (MT1-MMP) is one of the major proteinases that degrades collagen and is the most abundant MMP form in the uterus. Matrix metalloproteinase-2(MMP-2) can degrade type I collagen, although its main function is to degrade type IV collagen found in the basement membrane. To understand the expression patterns of matrix metalloproteinases (MMPs) in the rat uterus, we analyzed their activities in postpartum uterine involution.
We performed gelatin zymography, northern blot analysis and immunohistochemistry to compare the expression levels of MT1-MMP, MMP-2, matrix metalloproteinase-9 (MMP-9) and the tissue inhibitors of MMPs-1 and 2 (TIMP-1 and TIMP-2) in the rat uterus 18 h, 36 h and 5 days after parturition with their expression levels during pregnancy (day 20).
We found that both MT1-MMP and MMP-2 localized mainly in the cytoplasm of uterine interstitial cells. The expression levels of MT1-MMP and MMP-2 mRNAs and the catalytic activities of the expressed proteins significantly increased 18 h and 36 h after parturition, but at postpartum day 5, their mRNA expression levels and catalytic activities decreased markedly. The expression levels of MMP-9 increased 18 h and 36 h after parturition as determined by gelatin zymography including the expression levels of TIMP-1 and TIMP-2.
These expression patterns indicate that MT1-MMP, MMP-2, MMP-9, TIMP-1 and TIMP-2 may play key roles in uterine postpartum involution and subsequent functional regenerative processes.
During pregnancy, the uterus enlarges, which in rats is mainly caused by an increase in the amount of collagen and hypertrophy of the uterine smooth muscle cells. After parturition, the uterus undergoes involution during which it returns to its prepregnancy state. Matrix metalloproteinases (MMPs) are a group of structurally related endopeptidases that catalyze the degradation of various macromolecular components of the extracellular matrix and basement membrane [1, 2], and induce various forms of tissue remodeling, including wound healing [3, 4], trophoblast invasion [5, 6], organ morphogenesis [7, 8], and uterine [9–11], mammary gland [12, 13], and prostate gland [14, 15] involution. We previously reported that an increase in the expression levels of both membrane type 1-MMP (MT1-MMP) and MMP-2 plays a key role in tissue remodeling during corpus luteum structural involution both in rats and humans [16–18].
To obtain additional information on the activity of MMPs during uterine involution, we have initiated studies using a rat model to examine MMP expression and function in the uterus during pregnancy and after parturition. Although MT1-MMP is abundant in the uterus [19, 20], little is known about its activity or that of MMP-2 during uterine involution. To the reason for this, we investigated the expression patterns of MT1-MMP, MMP-2, MMP-9, TIMP-1 and TIMP-2 and the activation of MMP-2 in the rat uterus during postpartum involution.
Materials and methods
Pregnant Sprague-Dawley rats were obtained from Hokudo Co., (Sapporo, Japan) on day 17 of gestation, after which they were kept in our laboratory and maintained on a 12-hour light and 12-hour dark regimen (light 7:00–19:00) with free access to water and a standard diet. Uterine tissue for postpartum involution analysis was obtained from five rats per group on gestation day 20 and then 18 h, 36 h and 5 days after parturition. The Animal Care and Use Committee of the Sapporo Medical University School of Medicine approved all procedures of this study, which are in accordance with the standards described in the National Institutes of Health Guide for Care and Use of Laboratory Animals.
Each uterine tissue sample was divided into two pieces. One piece was fixed in 4% paraformaldehyde/PBS and embedded in paraffin for immunohistological analysis. The other was used for biochemical studies (zymography and northern blotting); all tissue samples were frozen on dry ice and then stored at -80°C until use.
Ultraspec RNA was purchased from Biotex Laboratories, Inc. (Houston, TX); 3,3'-diaminobenzidine (DAB) was purchased from Katayama Chemical (Osaka, Japan); Nytran-Plus was purchased from Schleicher & Schuell (Keene, NH); 32P-dCTP and a Nick column were purchased from Amersham Pharmacia Biotech (Buckinghamshire, England); Prime-It II random primer labeling kits were purchased from Stratagen (La Jolla, CA); rabbit anti-rat MT1-MMP antiserum and anti-MMP-2 antibodies were purchased from Fuji Chemical Industries, Ltd. (Toyama, Japan); biotinylated antibodies and Vectastain ABC Elite kits were purchased from Vector Laboratories (Burlingame, CA); fetal calf serum (FCS) was purchased from Gibco (Grand Island, NY); APS-coated glass slides were purchased from Matsunami (Tokyo, Japan); STUF solution was purchased from Serotec Ltd. (Kidlington, Oxford, UK); and Block Ace was purchased from Dainippon Pharmaceutical Co. (Osaka, Japan).
Total RNA was extracted from uterine tissue samples using an Ultraspec RNA isolation system, after which the extracted RNA (20 μg/lane) was electrophoresed on 1% agarose/formaldehyde gels (100 V; 2 h), transferred overnight onto nylon membranes in 20 × SSC (3 M sodium chloride, 0.3 M trisodium citrate) and fixed using a UV linker. Filters were prehybridized for 4 h and then hybridized overnight at 42°C with a 32P-labeled cDNA probe. The probes used for Northern blotting were a 1.2-kb Hind-III- and Eco R-digested fragment of MT1-MMP cDNA, a 1.5-kb Eco RI- and Bam-HI- digested fragment of MMP-2 cDNA, a 0.6-kb Cla-I- and Bam-HI-digested fragment of TIMP-1 cDNA, and a 0.7-kb Eco-RI- and Bg-II-digested fragment of TIMP-2 cDNA . A 450-bp cDNA fragment encoding the ribosomal protein L38 was used as an internal control .
The probes were radiolabeled with 32P-dCTP using Prime-It II random primer labeling kits, after which the labeled probes were purified on a Nick column before hybridization. After hybridization, the filters were washed four times: twice for 15 min each with 2 × SSC containing 0.1% SDS at room temperature, and twice for 15 min each with 0.2 × SSC containing 0.1% SDS at 65°C. The filters were then exposed to a Fuji RX X-ray film at -70°C for 1–2 days.
Gelatin zymography was carried out as previously described . Briefly, uterine samples were homogenized (100 mg wet weight/ml of PBS containing 0.2% Triton X-100) using a Teflon glass tissue grinder on ice (15 strokes). The resulting homogenates were centrifuged at 12,000 × g for 20 min at 4°C, after which the supernatants were collected as the uterine extract. After assaying the protein concentration, aliquots of the extract (40 μg of protein) were electrophoresed in 10% polyacrylamide gels containing 1 mg/ml gelatin.
Gelatin zymography using crude membrane fraction from rat uterus
The crude membrane fraction from the rat uterus was isolated as previously reported [17, 23]. Briefly, uterine tissue samples were homogenized in 2 ml of Tris buffer containing 0.25 M sucrose using a Teflon glass tissue grinder at 45 × g on ice. The resulting homogenates were filtered through a nylon mesh (42 μm) and centrifuged at 120 × g for 10 min. The supernatant was then collected and centrifuged at 10,000 × g for 30 min at 4°C, and the pellet was collected as the crude membrane fraction and stored at -80°C until use. To examine the expression level of membrane-bound pro-MMP-2, aliquots of the crude uterine membrane fraction (20 μg) were mixed with 1 μl of FCS as a source of procollagenase and incubated for 2 h at 37°C. After terminating the procollagenase activity by adding of the sample buffer, the expression level of membrane-bound pro-MMP-2 as estimated from the liberated MMP-2 activity as determined by gelatin zymography.
The uterine tissues embedded in paraffin were cut into 5-μm-thick sections and mounted on APS-coated glass slides. The sections were then deparaffinized with xylene and the slides were placed on a hot plate at 90°C, covered with a STUF solution for 10 min, and then rinsed several times with PBS. Endogenous peroxidase activity was blocked by incubating the slides in 0.6% H2O2 in methanol for 30 min at room temperature, after which Block Ace was applied for 30 min at room temperature to minimize nonspecific antibody binding. Primary antibodies were then applied to the sections for 60 min at room temperature, after which the sections were incubated with a biotinylated secondary antibody for 30 min. The sections were then stained using the ABC method with DAB as a substrate; hematoxylin and eosin stain was used as the counterstain. As a negative control, the slides were processed without incubation with primary antibodies. The sections were also stained with hematoxylin and eosin.
Bands showing gelatinase activity were analyzed using NIH Image software (Version 1.61). Bands on Northern blots were analyzed using a BAS 2000 Bio-Imaging Analyzer (FUJI, Tokyo, Japan). Radioactivity was normalized to that in the L38 RNA band.
Data are presented as mean ± SEM. The differences between groups were evaluated using one-way ANOVA with post hoc Schaffer's F-test and unpaired Student's t-test. Values of P < 0.05 were considered significant.
Time-dependent localization of MMP-2 and MT1-MMP proteins in rat uterus
Expression levels of MMP-2, MT1-MMP, TIMP-1 and TIMP-2 mRNAs in rat uterus
Gelatinase activity in extracts of rat uterus
Expression levels of pro-MMP-2 in uterine plasma membrane fractions
Immunohistochemical staining revealed that both MT1-MMP and MMP-2 proteins mainly localized in the cytoplasm of the uterine interstitial cells 18 h (not shown) and 36 h after parturition. Moreover, MMP-2 mRNA and MT1-MMP mRNA expressen levels time-dependently increased for at least 36 h. The level of the 62-kDa activated form of MMP-2 also increased 18 h and 36 h after parturition. The expression levels of gelatinase activity of the uterine tissue extract in the uterine plasma membrane fraction increased 18 h and 36 h after parturition. These results indicate that MMP-2 and MT1-MMP may play key roles in uterine postpartum involution
During pregnancy, the uterus is transformed into a large muscular organ sufficient to accommodate the fetus, placenta and amniotic fluid. After parturition, the uterus undergoes involution, a conspicuous feature characterized by the rapid decrease in the amount of collagen resulting from the extracellular degradation of collagen bundles. Activated collagenases cleave the collagen bundles into fragments, which then denature at body temperature into gelatin. Gelatinases then cleave the gelatin in small peptides that are rapidly removed in the blood stream . To better understand the functions of MMPs in various uterine processes, we have initiated studies using a rat model for studying the activities of various MMPs in the uterus during pregnancy and after parturition. MT1-MMP, for example, has various functions that include the degradation of several types of collagen, the activations of other MMPs and activities related to apoptosis. This study showed that the expression levels of MT1-MMP and MMP-2 were significantly increased in the cytoplasm of uterine interstitial cells in the first five days after parturition, which suggests that these two enzymes play important roles in the postpartum involution of the enlarged uterus in rats. Various of MMPs are reportedly involved in tissue remodeling during postpartum uterine involution. Stygar et al. reported that cervical stromal fibroblasts and smooth muscle cells were identified as the main sources of MMP-2, whereas MMP-9 protein was observed only in invading leukocytes. MMP-2 and MMP-9 are involved also in the cervical ripening process . Lyons et al. reported that MMP-9 may be involved in preterm labor, cervical maturity, and postpartum uteruine involution . Roh et al. reported that the proMMP-9 in the uterine tissue maybe related to the remodelling of human myometrium during labor . We also consider that MMP-9 is related to postpartum uterine involution from the results of our gelatine zymograpy experiment (Fig. 3(a)).
Evidence suggests that MT1-MMP causes the degradation of collagen types I, IV and V and elastin [28, 29], and activates membrane-bound pro-MMP-2 [30–33]. Although it is thought that the main function of the activated MMP-2 is the degradation of type IV collagen in the basement membrane, it also cleaves type I collagen , which is consistent with the finding that during postpartum uterine involution, MT1-MMP and MMP-2 act together to degrade the abundant type I collagen.
We found that the time courses of the expressions of MMP-2, TIMP-1 and TIMP-2 differed from those described in the reports mentioned above. This difference is reflected in part by the transiently high expression level of TIMP-1 observed 18 h after parturition. Because TIMP-1 is known to bind stoichiometrically to almost all MMP active sites, thereby irreversibly inhibiting the enzyme's activity [33, 35], its upregulation would be expected to mitigate the effect of the abrupt concurrent increase in MMP expression level. On the other hand, the suppression of TIMP-1 transcription 36 h after parturition would likely contribute to the maintenance of a high MMP activity.
In contrast to TIMP-1, TIMP-2 transcription was enhanced only slightly 5 days after parturition. Although TIMP-2 exerts a strong inhibitory effect on MMPs similar to TIMP-1 , it also forms MT1-MMP/TIMP-2 and MT1-MMP/TIMP-2/pro-MMP-2 complexes, which are involved in the activation of pro-MMP-2 [37–39]. This suggests that at 18 h and 36 h postpartum the slight increase in TIMP-2 expression level induced proMMP-2 activation. In contrast, the much larger increase in TIMP-2 expression level observed 5 days after parturition, which coincides with the decrease in the activities of MT1-MMP and MMP-2, mediated pro-MMP-2 suppression. Taken together, these findings strongly suggest that MT1-MMP, MMP-2 and MMP-9 are time-dependently regulated and play important roles in tissue remodeling during postpartum uterine involution.
This work was supported by a Grant-in-Aid for Scientific Research (11671637) of the Ministry of Education, Culture, Sports, Science and Technology, Japan to T. Endo. We thank Dr. Takehara for helpful discussions on the histology of the rat uterus.
- Woessner JF: Matrix metalloproteinase and their inhibitors in connective tissue remodeling. FASEB J. 1991, 5 (8): 2145-2154.PubMedGoogle Scholar
- Matrisian LM: The matrix-degrading metalloproteinases. Bioessays. 1992, 14 (7): 455-463. 10.1002/bies.950140705.View ArticlePubMedGoogle Scholar
- Oikarinen A, Kylmefniemi M, Autio-Harmainen H, Autio P, Salo T: Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol. 1992, 101 (2): 205-210. 10.1111/1523-1747.ep12363823.View ArticleGoogle Scholar
- Saarialho-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC: Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest. 1993, 92 (3): 2858-2866.PubMed CentralView ArticlePubMedGoogle Scholar
- Shimonnvitz S, Hurwitz A, Dushnik M, Anteby E, Geva-Eldar T, Yagel S: Developmental regulation of the expression of 72 and 92 kd type IV collagenase in human trophoblast: a possible mechanism for control of trophoblast invasion. Am J Obstet Gynecol. 1994, 171 (3): 832-838.View ArticleGoogle Scholar
- Lala PK, Graham CH: Mechanisms of trophoblast invasiveness and their control: the role of protease inhibitors. Cancer Metastasis Rev. 1991, 9 (4): 369-379.View ArticleGoogle Scholar
- Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z: Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinase in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol. 1994, 125 (3): 681-693. 10.1083/jcb.125.3.681.View ArticlePubMedGoogle Scholar
- Witty JP, Wright J, Matrisian LM: Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell. 1995, 6 (10): 1287-1303.PubMed CentralView ArticlePubMedGoogle Scholar
- Woessner JF, Taplin C: Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem. 1988, 263 (3): 16918-16925.PubMedGoogle Scholar
- Sellers A, Woessner JF: The extraction of a neutral metalloproteinase from the involuting rat uterus, and its action on cartilage proteoglycan. Biochem J. 1980, 189 (3): 521-531.PubMed CentralView ArticlePubMedGoogle Scholar
- Jeffrey JJ, Gross J: Collagenase from rat uterus.: Isolation and partial characterization. Biochemistry. 1970, 9 (2): 268-273. 10.1021/bi00804a012.View ArticlePubMedGoogle Scholar
- Talhouk RS, Bissell MJ, Werb Z: Expression of extracellular matrix degrading proteinases and their inhibitors during involution of the mammary gland in CD-1 mice. J Cell Biol. 1990, 111 (1): 14a-Google Scholar
- Talhouk RS, Bissell MJ, Werb Z: Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol. 1992, 118 (5): 1271-1282. 10.1083/jcb.118.5.1271.View ArticlePubMedGoogle Scholar
- Wilson MJ, Norris H, Woodson M, Sinha AA: Effect of castration on melloproteinase activities in the lateral, dorsal, and anterior lobes of the prostate. Arch Androl. 1995, 35 (2): 119-125.View ArticlePubMedGoogle Scholar
- Powell WC, Dormann FE, Michen JM, Matrisian LM, Nagle RB, Bowden GT: Matrilysin expression in the involuting rat ventral prostate. Prostate. 1996, 29 (3): 159-168.View ArticlePubMedGoogle Scholar
- Endo T, Aten RF, Wang F, Behrman HR: Coordinate induction and activation of metalloproteinase and ascorbate depletion in structural luteolysis. Endocrinology. 1993, 133 (2): 690-698. 10.1210/en.133.2.690.PubMedGoogle Scholar
- Goto T, Endo T, Henmi H, Kitajima Y, Kiya T, Nishikawa A, Manase K, Sato H, Kudo R: Gonadotripin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type-1 MMP expression in corpora lutea, and structural luteolysis in rats. J Endocrinol. 1999, 393-402. 10.1677/joe.0.1610393. 3
- Manase K, Endo T, Henmi H, Kitajima Y, Yamazaki K, Nishikawa A, Mitaka T, Sato H, Kudo R: The significance of membrane type 1 metalloproteinase in structural involution of human corpora lutea. Mol Hum Reprod. 2002, 8 (8): 742-749. 10.1093/molehr/8.8.742.View ArticlePubMedGoogle Scholar
- Harkness RD, Moralee BE: The time course and route of loss of collagen from the rat's uterus during post-partum involution. J Physiol. 1956, 132 (3): 502-508.PubMed CentralView ArticlePubMedGoogle Scholar
- Liu X, Wu H, Byrne M, Jeffrey J, Krane S, Jaenisch R: A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol. 1995, 130 (1): 227-237. 10.1083/jcb.130.1.227.View ArticlePubMedGoogle Scholar
- Nishikawa A, Iwasaki M, Akutagawa N, Manase K, Yamashita S, Endo T, Kudo R: Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: Correlation to invasive potential. Gynecol Oncol. 2000, 79 (2): 256-263. 10.1006/gyno.2000.5944.View ArticlePubMedGoogle Scholar
- Kuwano Y, Olvera J, Wool IG: The primary structure of rat ribosomal protein L38. Biochem Biophys Res. 1991, 175 (2): 551-555. 10.1016/0006-291X(91)91600-H.View ArticleGoogle Scholar
- Luborsky JL, Dorflinger LJ, Wright K, Berman HR: Prostaglandin F2αinhibits luteinizing hormone (LH)-induced increase in LH receptor binding to isolated rat luteal cells. Endocrinology. 1984, 115: 2210-2216.View ArticlePubMedGoogle Scholar
- Shimizu K, Furuya T, Takeo Y, Shirama K, Maekawa K: Clearance of materials from breakdown of uterine collagen in mice during postpartum involution. Acta Anat (Basel). 1983, 116 (1): 10-13.View ArticleGoogle Scholar
- Stygar D, Wang H, Vladic YS, Ekman G, Eriksson H, Sahlin L: Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod. 2002, 67: 889-94. 10.1095/biolreprod.102.005116.View ArticlePubMedGoogle Scholar
- Regulation of matrix metalloproteinases (type IV collagenases) and their inhibitors in the virgin, timed pregnant, and postpartum rat uterus and cervix by prostaglandin E(2)-cyclic adenosine monophosphate. Am J Obstet Gynecol. 2002, 187 (1): 202-8. 10.1067/mob.2002.123543.
- Roh CR, Oh WJ, Yoon BK, Lee JH: Up-regulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells. Mol Hum Reprod. 2000, 6: 96-102. 10.1093/molehr/6.1.96.View ArticlePubMedGoogle Scholar
- Shimada H, Okamura H, Espey LL, Mori T: Increase in plasminogen activator in the involuting uterus of the postpartum rat. J Endocrinol. 1985, 104 (2): 295-298.View ArticlePubMedGoogle Scholar
- Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993, 4 (2): 197-250.PubMedGoogle Scholar
- Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature. 1994, 370 (6484): 61-65. 10.1038/370061a0.View ArticlePubMedGoogle Scholar
- Takino T, Sato H, Yamamoto E, Seiki M: Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain. Gene. 1955, 155 (2): 293-298. 10.1016/0378-1119(94)00637-8.View ArticleGoogle Scholar
- Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T, Seiki M: Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type I matrix metalloproteinase. Cancer Res. 1996, 56 (11): 2535-2538.PubMedGoogle Scholar
- Umenishi F, Umeda M, Miyazaki K: Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on mettaloproteinase and in vitro tumor invasion. J Cell Biol. 1991, 110 (2): 189-195.Google Scholar
- Aimes RT, Quigley JP: Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem. 1995, 270 (11): 5872-5876. 10.1074/jbc.270.11.5872.View ArticlePubMedGoogle Scholar
- Willenbrock F, Murphy G: Structure-function relationships in the tissue inhibitory effects of metalloproteinase. Am J Respir Crit Care Med. 1994, 150 (6Pt2): S165-S170.View ArticlePubMedGoogle Scholar
- Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase 2 (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem. 1989, 264 (29): 5331-239.Google Scholar
- Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y: Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase 2. Cancer Res. 1996, 56 (2): 2707-2710.PubMedGoogle Scholar
- Sato H, Okada Y, Seiki M: Membrane-type matrix metalloproteinases (MT-MMPs) in cell invation. Thromb Haemost. 1997, 78 (1): 497-500.PubMedGoogle Scholar
- Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, Seiki M: TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem. 1998, 273 (26): 16098-16103. 10.1074/jbc.273.26.16098.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.